A phase II randomized study comparing navelbine and capecitabine (Navcap) followed either by Navcap or by weekly docetaxel in the first-line treatment of HER-2/neu negative metastatic breast cancer

2010 ◽  
Vol 28 (S1) ◽  
pp. 142-151 ◽  
Author(s):  
M. Ghosn ◽  
P. Aftimos ◽  
F. S. Farhat ◽  
J. G. Kattan ◽  
C. Hanna ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase Ii ◽  
Randomized Study ◽  
Metastatic Breast ◽  
Line Treatment ◽  
First Line ◽  
Weekly Docetaxel ◽  
Her 2 ◽  
First Line Treatment

scholarly journals Phase II, multicenter, open-label, randomized study of YM155 plus docetaxel as first-line treatment in patients with HER2-negative metastatic breast cancer

2014 ◽  
Vol 149 (1) ◽  
pp. 171-179 ◽  
Author(s):  
Michael R. Clemens ◽  
Oleg A. Gladkov ◽  
Elaina Gartner ◽  
Vladimir Vladimirov ◽  
John Crown ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase Ii ◽  
Randomized Study ◽  
Metastatic Breast ◽  
Line Treatment ◽  
First Line ◽  
Open Label ◽  
First Line Treatment

Phase II Trial of Weekly Docetaxel, Vinorelbine, and Trastuzumab in the First-Line Treatment of Patients with HER2-Positive Metastatic Breast Cancer

2009 ◽  
Vol 9 (1) ◽  
pp. 23-28 ◽  
Author(s):  
Jeffrey R. Infante ◽  
Denise A. Yardley ◽  
Howard A. Burris ◽  
F. Anthony Greco ◽  
Cindy P. Farley ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Metastatic Breast ◽  
Line Treatment ◽  
First Line ◽  
Her2 Positive ◽  
Weekly Docetaxel ◽  
First Line Treatment

scholarly journals Weekly Docetaxel and Gemcitabine as First-Line Treatment for Metastatic Breast Cancer: Results of a Multicenter Phase II Study

Oncology ◽  
2005 ◽  
Vol 68 (4-6) ◽  
pp. 438-445 ◽  
Author(s):  
S. Palmeri ◽  
M. Vaglica ◽  
S. Spada ◽  
G. Filippelli ◽  
A. Farris ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Metastatic Breast ◽  
Line Treatment ◽  
First Line ◽  
Weekly Docetaxel ◽  
Multicenter Phase ◽  
First Line Treatment

Exemestane and Chemotherapy as First-line Treatment of Metastatic Breast Cancer: Results of a Phase II Study

2010 ◽  
Vol 10 (4) ◽  
pp. 313-317 ◽  
Author(s):  
Juan de la Haba-Rodriguez ◽  
Rosario González Mancha ◽  
Gumersindo Pérez Manga ◽  
Enrique Aranda Aguilar ◽  
José Manuel Baena Cañada ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Metastatic Breast ◽  
Line Treatment ◽  
First Line ◽  
First Line Treatment
Sign in / Sign up

Export Citation Format

Share Document